SCHEMBL19080027

SCHEMBL19080027

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5oc6c7ccccc7c7ccccc7c6c5c5ccccc45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
GSK3B P49841 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34
CDC14B O60729 1/20 0.33
CDC14A Q9UNH5 1/20 0.33
ALOX5 P09917 2/20 0.33
AHR P35869 1/20 0.33
MEN1 O00255 5/20 0.32
KMT2A Q03164 5/20 0.32
KDM4E B2RXH2 2/20 0.32
GAA P10253 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPT P10636 2/20 0.32
CYP3A4 P08684 2/20 0.32
HPGD P15428 2/20 0.32
ALPI P09923 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079930 0.88 GPR84 (0.39) CA1CA2CDK1CCNB1GSK3B
SCHEMBL19076426 0.88 ALOX5 (0.37) CA1CA2CDC14BCDC14AALOX5
SCHEMBL17944829 0.85 CDC14B (0.41) CA1CA2CDC14BCDC14AALOX5
SCHEMBL19080089 0.85 CYP1A1 (0.36) ALOX5HSD17B10CYP3A4HPGDALDH1A1
SCHEMBL19076423 0.85 ALOX5 (0.39) CA1CA2CDC14BCDC14AALOX5
SCHEMBL19080059 0.84 ALOX5 (0.38) ALOX5AHRMEN1KMT2AKDM4E
SCHEMBL24004243 0.83 CA1 (0.41) CA1CA2CDC14BCDC14AALOX5
SCHEMBL19076424 0.82 CDC14B (0.38) CA1CA2CDC14BCDC14AALOX5
SCHEMBL19076393 0.82 CA1 (0.38) CA1CA2CDK1CCNB1GSK3B
SCHEMBL17944704 0.82 CA1 (0.40) CA1CA2CDC14BCDC14AAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CA1 1453/4885CA2 2870/4885CDK1 15/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CA1 1453/4885CA2 2870/4885CDK1 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.